The US Food and Drug Administration confirmed that it has approved Sunovion Pharmaceuticals’ Aptiom drug.

The drug though has the same side-effects as other anti-seizure drugs, with symptoms ranging from headache, nausea, drowsiness, dizziness, double-vision, vomiting, and fatigue, while it was also found to increase suicidal thoughts among a small number of patients.
“Some patients with epilepsy do not achieve satisfactory seizure control from existing treatments. It is important we continue to make new treatment options available to patients”, Dr Eric Bastings from FDA’s Center for Drug Evaluation and Research said.
Source-Medindia